Kidney/Renal Conditions

Main Content

ADRENL Study

Study title

ACTHAR for the management of treatment-resistant nephrotic syndrome in children

  • Principal Investigator: Dr. Mehul Dixit

Purpose

This study is looking at the efficacy of a drug for treatment of steroid-resistant nephrotic syndrome in the pediatric population.

Who can participate

Those eligible to participate in this study include:

  • Patients age 2-21 who fail a minimum of 12 weeks of cumulative therapy with prednisone or on other agent for treatment of nephrotic syndrome.

For more information

  • Cathy Hudgins, RN
    University of Mississippi Medical Center
    2500 N. State St.
    Jackson MS 39216
    (601) 815-9276
  • IRB Number: 2018-0021